Lessons from models of SOD1-linked familial ALS

Trends in Molecular Medicine

Volumn 10, Issue 8, 2004, Pages 393-400

  Bendotti, Caterina ^a   Carrì, Maria Teresa ^b,c  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c IRCCS FONDAZIONE SANTA LUCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMPA RECEPTOR ANTAGONIST; COPPER ZINC SUPEROXIDE DISMUTASE; CYCLOOXYGENASE 2 INHIBITOR; CYCLOSPORIN A; MINOCYCLINE; MUTANT PROTEIN; TETRACYCLINE DERIVATIVE;

AMYOTROPHIC LATERAL SCLEROSIS; CELL FUNCTION; CELL TYPE; CYTOSKELETON; DEGENERATIVE DISEASE; GENE MUTATION; GENETIC CODE; GENETIC LINE; HUMAN; MOTONEURON; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PROTEIN AGGREGATION; PROTEIN DEFECT; PROTEIN EXPRESSION; REVIEW;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; HUMANS; LINKAGE (GENETICS); MICE; MICE, TRANSGENIC; MOTOR NEURONS; MUTATION; SUPEROXIDE DISMUTASE;

EID: 4043075622     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmed.2004.06.009     Document Type: Review

References (75)

1. D.R. Rosen Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis Nature 362 1993 59 62
2. J.S. Valentine Do oxidatively modified proteins cause ALS? Free Radic. Biol. Med. 33 2002 1314 1320
3. J.A. Rodriguez Familial ALS-associated mutations decrease the thermal stability of distinctly metallated species of human copper-zinc superoxide dismutase J. Biol. Chem. 277 2002 15932 15937
4. R. Rakhit Oxidation-induced misfolding and aggregation of superoxide dismutase and its implications for amyotrophic lateral sclerosis J. Biol. Chem. 277 2002 47551 47556
5. P.B. Stathopulos Cu/Zn superoxide dismutase mutants associated with amyotrophic lateral sclerosis show enhanced formation of aggregates in vitro Proc. Natl. Acad. Sci. U. S. A. 100 2003 7021 7026
6. J.S. Elam Amyloid-like filaments and water-filled nanotubes formed by SOD1 mutant proteins linked to familial ALS Nat. Struct. Biol. 10 2003 461 467
7. J.R. Subramaniam Mutant SOD1 causes motor neuron disease independent of copper chaperone-mediated copper loading Nat. Neurosci. 5 2002 301 307
8. J. Wang Copper-binding-site-null SOD1 causes ALS in transgenic mice:aggregates of non-native SOD1 delineate a common feature Hum. Mol. Genet. 12 2003 2753 2764
9. M.C. Carroll Mechanisms for activating Cu- and Zn-containing superoxide dismutase in the absence of the CCS Cu chaperone Proc. Natl. Acad. Sci. U. S. A. 101 2004 5964 5969
10. L.J. Hayward Decreased metallation and activity in subsets of mutant superoxide dismutases associated with familial amyotrophic lateral sclerosis J. Biol. Chem. 277 2002 15923 15931
11. J.S. Beckman Superoxide dismutase and the death of motoneurons in ALS Trends Neurosci. 24 2001 S15 S20
12. M.F. Beal Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis Ann. Neurol. 42 1997 644 654
13. L.I. Bruijn Elevated free nitrotyrosine levels, but not protein-bound nitrotyrosine or hydroxyl radicals throughout amyotrophic lateral sclerosis (ALS)-like disease implicate tyrosine nitration as an aberrant in vivo property of one familial ALS-linked superoxide dismutase 1 mutant Proc. Natl. Acad. Sci. U. S. A. 94 1997 7606 7611
14. M.E. Gurney Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation Science 264 1994 1772 1775
15. M. Nagai Rats expressing human cytosolic copper-zinc superoxide dismutase transgenes with amyotrophic lateral sclerosis: associated mutations develop motor neuron disease J. Neurosci. 21 2001 9246 9254
16. Newbery, H. and J.and Abbott, C.M. (2002) Of mice, men and motor neurons. Trends Mol. Med. 8, 88-92.
17. V. Kostic Midbrain dopaminergic neuronal degeneration in a transgenic mouse model of familial amyotrophic lateral sclerosis Ann. Neurol. 41 1997 497 504
18. N. Shibata Transgenic mouse model for familial amyotrophic lateral sclerosis with superoxide dismutase-1 mutation Neuropathology 21 2001 82 92
19. C. Bendotti Early vacuolization and mitochondrial damage in motor neurons of FALS mice are not associated with apoptosis or with changes in cytochrome oxidase histiochemical reactivity J. Neurol. Sci. 191 2001 25 33
20. C. Jung Mitochondrial electron transport chain complex dysfunction in a transgenic mouse model for amyotrophic lateral sclerosis J. Neurochem. 83 2002 535 545
21. 2+ concentration in transfected neuroblastoma SH-SY5Y cells FEBS Lett. 414 1997 365 368
22. M.F. Beal Mitochondria and the pathogenesis of ALS Brain 123 2000 1291 1292
23. L. Siklos Ultrastructural evidence for altered calcium in motor nerve terminals in amyotropic lateral sclerosis Ann. Neurol. 39 1996 203 216
24. A. Ferri Calcineurin activity is regulated both by redox compounds and by mutant FALS-SOD1 J. Neurochem. 75 2000 606 613
25. M.R. Ciriolo Cu,Zn superoxide dismutase-dependent apoptosis induced by nitric oxide in neuronal cells J. Biol. Chem. 275 2000 5065 5072
26. D. Liu The roles of free radicals in amyotrophic lateral sclerosis: reactive oxygen species and elevated oxidation of protein, DNA, and membrane phospholipids FASEB J. 13 1999 2318 2328
27. M. Mattiazzi Mutated human SOD1 causes dysfunction of oxidative phosphorylation in mitochondria of transgenic mice J. Biol. Chem. 277 2002 29626 29633
28. M. Friedlander Apoptosis and caspases in neurodegenerative diseases N. Engl. J. Med. 348 2003 1365 1375
29. A. Migheli Lack of apoptosis in mice with ALS Nat. Med. 5 1999 966 967
30. G.D. Ghadge Mutant superoxide dismutase-1-linked familial amyotrophic lateral sclerosis: molecular mechanisms of neuronal death and protection J. Neurosci. 17 1997 8756 8766
31. P. Pasinelli Caspase-1 and -3 are sequentially activated in motor neuron death in Cu,Zn superoxide dismutase-mediated familial amyotrophic lateral sclerosis Proc. Natl. Acad. Sci. U. S. A. 97 2000 13901 13906
32. C. Guégan, and S. Przedborski Programmed cell death in amyotrophic lateral sclerosis J. Clin. Invest. 111 2003 153 161
33. M. Li Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model Science 288 2000 335 339
34. H. Inoue The crucial role of caspase-9 in the disease progression of a transgenic ALS mouse model EMBO J. 22 2003 6665 6674
35. A. Okado-Matsumoto, and I. Fridovich Amyotrophic lateral sclerosis: a proposed mechanism Proc. Natl. Acad. Sci. U. S. A. 99 2002 9010 9014
36. J.A. Johnston Formation of high molecular weight complexes of mutant Cu, Zn-superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis Proc. Natl. Acad. Sci. U. S. A. 97 2000 12571 12576
37. J-P. Julien Amyotrophic lateral sclerosis. unfolding the toxicity of the misfolded Cell 104 2001 581 591
38. S. Kato New consensus research on neuropathological aspects of familial amyotrophic lateral sclerosis with superoxide dismutase 1 (SOD1) gene mutations: inclusions containing SOD1 in neurons and astrocytes Amyotroph. Lateral Scler. Other Motor Neuron Disord. 1 2000 163 184
39. M. Tortarolo Persistent activation of p38 mitogen-activated protein kinase in a mouse model of familial amyotrophic lateral sclerosis correlates with disease progression Mol. Cell. Neurosci. 23 2003 180 192
40. C. Bendotti Activated p38MAPK is a novel component of the intracellular inclusions found in human amyotrophic lateral sclerosis and mutant SOD1 transgenic mice J. Neuropathol. Exp. Neurol. 63 2004 113 119
41. S. Allen Analysis of the cytosolic proteome in a cell culture model of familial amyotrophic lateral sclerosis reveals alterations to the proteasome, antioxidant defenses, and nitric oxide synthetic pathways J. Biol. Chem. 278 2003 6371 6383
42. M. Urushitani Proteasomal inhibition by misfolded mutant superoxide dismutase 1 induces selective motor neuron death in FALS J. Neurochem. 83 2002 1030 1042
43. J.D. Rothstein Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis N. Engl. J. Med. 326 1992 1464 1468
44. D. Trotti SOD1 mutants linked to amyotrophic lateral sclerosis selectively inactivate a glial glutamate transporter Nat. Neurosci. 2 1999 427 433
45. C. Bendotti Transgenic SOD1 G93A mice develop reduced GLT-1 in spinal cord without alterations in cerebrospinal fluid glutamate levels J. Neurochem. 79 2001 737 746
46. D.S. Howland Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS) Proc. Natl. Acad. Sci. U. S. A. 99 2002 1604 1609
47. H. Guo Increased expression of the glial glutamate transporter EAAT2 modulates excitotoxicity and delays the onset but not the outcome of ALS in mice Hum. Mol. Genet. 12 2003 2519 2532
48. T. Mennini Expression of glutamate receptor subtypes in the spinal cord of control and mnd mice, a model of motor neuron disorder J. Neurosci. Res. 70 2002 553 560
49. J.M. Anneser Differential expression of group I metabotropic glutamate receptors in rat spinal cord somatic and autonomic motoneurons: possible implications for the pathogenesis of amyotrophic lateral sclerosis Neurobiol. Dis. 6 1999 140 147
50. S.G. Carriedo Motor neurons are selectively vulnerable to AMPA/kainate receptor-mediated injury in vitro J. Neurosci. 16 1996 4069 4079
51. Y. Kawahara Glutamate receptors: RNA editing and death of motor neurons Nature 427 2004 801
52. P. Van Damme The AMPA receptor antagonist NBQX prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis Neurosci. Lett. 343 2003 81 84
53. C. Raoul Motoneuron death triggered by a specific pathway downstream of Fas. Potentiation by ALS-linked SOD1 mutations Neuron 35 2002 1067 1083
54. K. Hensley Temporal patterns of cytokine and apoptosis-related gene expression in spinal cords of the G93A-SOD1 mouse model of amyotrophic lateral sclerosis J. Neurochem. 82 2002 365 374
55. M.D. Nguyen Exacerbation of motor neuron disease by chronic stimulation of innate immunity in a mouse model of amyotrophic lateral sclerosis J. Neurosci. 24 2004 1340 1349
56. C.I. Cha Immunocytochemical study on the distribution of nitrotyrosine in the brain of the transgenic mice expressing a human Cu/Zn SOD mutation Brain Res. 853 2000 156 161
57. A. Migheli c-Jun, JNK/SAPK kinases and transcription factor NF-κB are selectively activated in astrocytes, but not motor neurons, in amyotrophic lateral sclerosis J. Neuropathol. Exp. Neurol. 56 1997 1314 1322
58. A. Casciati Oxidative modulation of nuclear factor-κB in human cells expressing mutant fALS-typical superoxide dismutases J. Neurochem. 83 2002 1019 1029
59. G. Almer Increased expression of the pro-inflammatory enzyme cyclooxygenase-2 in amyotrophic lateral sclerosis Ann. Neurol. 49 2001 176 185
60. D.B. Drachman Cyclooxygenase 2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALS Ann. Neurol. 52 2002 771 778
61. G. Almer Increased levels of the pro-inflammatory prostaglandin PGE2 in CSF from ALS patients Neurology 58 2002 1277 1279
62. A. Pramatarova Neuron-specific expression of mutant superoxide dismutase 1 in transgenic mice does not lead to motor impairment J. Neurosci. 21 2001 3369 3374
63. M.M. Lino Accumulation of SOD1 mutants in postnatal motoneurons does not cause motoneuron pathology or motoneuron disease J. Neurosci. 22 2002 4825 4832
64. Y.H. Gong Restricted expression of G86R Cu/Zn superoxide dismutase in astrocytes results in astrocytosis but does not cause motoneuron degeneration J. Neurosci. 20 2000 660 665
65. Ferri, A. et al. (2004) Cell death in amyotrophic lateral sclerosis: interplay between neuronal and glial cells. FASEB J. Doi: 10.1096/fj.03-1199fje (http://www.fasebj.org/)
66. S. Zhu Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice Nature 417 2002 74 78
67. A.M. Clement Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice Science 302 2003 113 117
68. S.D. Rao Disruption of glial glutamate transport by reactive oxygen species produced in motor neurons J. Neurosci. 23 2003 2627 2633
69. J.S. Henkel Presence of dendritic cells, MCP-1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue Ann. Neurol. 55 2004 221 235
70. P. Klivnyi Additive neuroprotective effects of creatine and cycloxygenase inhibitors in a transgenic mouse model of amyotrophic lateral sclerosis J. Neurochem. 88 2004 576 582
71. H. Ding Selective silencing by RNAi of a dominant allele that causes amyotrophic lateral sclerosis Aging Cell 2 2003 209 217
72. M.M. Maxwell RNA interference-mediated silencing of mutant superoxide dismutase rescues cyclosporin A-induced death in cultured neuroblastoma cells Proc. Natl. Acad. Sci. U. S. A. 101 2004 3178 3183
73. D.D. Newmeyer, and S. Ferguson-Miller Mitochondria: releasing power for life and unleashing the machineries of death Cell 112 2003 481 490
74. V. Kostic Bcl-2: prolonging life in a transgenic mouse model of familial amyotrophic lateral sclerosis Science 277 1997 559 562
75. I.G. Kirkinezos An ALS mouse model with a permeable blood-brain barrier benefits from systemic cyclosporine A treatment J. Neurochem. 88 2004 821 826